Literature DB >> 22993437

Dependence of regenerated sensory axons on continuous neurotrophin-3 delivery.

Shaoping Hou1, LaShae Nicholson, Erna van Niekerk, Melanie Motsch, Armin Blesch.   

Abstract

Previous studies have shown that injured dorsal column sensory axons extend across a spinal cord lesion site if axons are guided by a gradient of neurotrophin-3 (NT-3) rostral to the lesion. Here we examined whether continuous NT-3 delivery is necessary to sustain regenerated axons in the injured spinal cord. Using tetracycline-regulated (tet-off) lentiviral gene delivery, NT-3 expression was tightly controlled by doxycycline administration. To examine axon growth responses to regulated NT-3 expression, adult rats underwent a C3 dorsal funiculus lesion. The lesion site was filled with bone marrow stromal cells, tet-off-NT-3 virus was injected rostral to the lesion site, and the intrinsic growth capacity of sensory neurons was activated by a conditioning lesion. When NT-3 gene expression was turned on, cholera toxin β-subunit-labeled sensory axons regenerated into and beyond the lesion/graft site. Surprisingly, the number of regenerated axons significantly declined when NT-3 expression was turned off, whereas continued NT-3 expression sustained regenerated axons. Quantification of axon numbers beyond the lesion demonstrated a significant decline of axon growth in animals with transient NT-3 expression, only some axons that had regenerated over longer distance were sustained. Regenerated axons were located in white matter and did not form axodendritic synapses but expressed presynaptic markers when closely associated with NG2-labeled cells. A decline in axon density was also observed within cellular grafts after NT-3 expression was turned off possibly via reduction in L1 and laminin expression in Schwann cells. Thus, multiple mechanisms underlie the inability of transient NT-3 expression to fully sustain regenerated sensory axons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993437      PMCID: PMC3513675          DOI: 10.1523/JNEUROSCI.5041-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

Review 1.  Axon retraction and degeneration in development and disease.

Authors:  Liqun Luo; Dennis D M O'Leary
Journal:  Annu Rev Neurosci       Date:  2005       Impact factor: 12.449

2.  Axon regeneration through scars and into sites of chronic spinal cord injury.

Authors:  Paul Lu; Leonard L Jones; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2006-10-02       Impact factor: 5.330

3.  Vesicular glutamate release from axons in white matter.

Authors:  Maria Kukley; Estibaliz Capetillo-Zarate; Dirk Dietrich
Journal:  Nat Neurosci       Date:  2007-02-11       Impact factor: 24.884

4.  Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord.

Authors:  Qin Chen; Lijun Zhou; H David Shine
Journal:  J Neurotrauma       Date:  2006-08       Impact factor: 5.269

5.  Vesicular release of glutamate from unmyelinated axons in white matter.

Authors:  Jennifer L Ziskin; Akiko Nishiyama; Maria Rubio; Masahiro Fukaya; Dwight E Bergles
Journal:  Nat Neurosci       Date:  2007-02-11       Impact factor: 24.884

6.  Transient growth factor delivery sustains regenerated axons after spinal cord injury.

Authors:  Armin Blesch; Mark H Tuszynski
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

7.  Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions.

Authors:  Kevin P Horn; Sarah A Busch; Alicia L Hawthorne; Nico van Rooijen; Jerry Silver
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

8.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.

Authors:  Anatoly Nikolaev; Todd McLaughlin; Dennis D M O'Leary; Marc Tessier-Lavigne
Journal:  Nature       Date:  2009-02-19       Impact factor: 49.962

9.  Overcoming macrophage-mediated axonal dieback following CNS injury.

Authors:  Sarah A Busch; Kevin P Horn; Daniel J Silver; Jerry Silver
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

10.  Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury.

Authors:  Laura Taylor Alto; Leif A Havton; James M Conner; Edmund R Hollis; Armin Blesch; Mark H Tuszynski
Journal:  Nat Neurosci       Date:  2009-08-02       Impact factor: 24.884

View more
  11 in total

Review 1.  Role of neurotrophin in the taste system following gustatory nerve injury.

Authors:  Lingbin Meng; Xin Jiang; Rui Ji
Journal:  Metab Brain Dis       Date:  2014-11-09       Impact factor: 3.584

2.  Electrospun Fibers for Drug Delivery after Spinal Cord Injury and the Effects of Drug Incorporation on Fiber Properties.

Authors:  Christopher D L Johnson; Anthony R D'Amato; Ryan J Gilbert
Journal:  Cells Tissues Organs       Date:  2016-10-05       Impact factor: 2.481

Review 3.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

4.  MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.

Authors:  Yu-Chao Zuo; Nan-Xiang Xiong; Jian-Ying Shen; Hua Yu; Yi-Zhi Huang; Hong-Yang Zhao
Journal:  Neurochem Res       Date:  2016-07-28       Impact factor: 3.996

Review 5.  Gene delivery strategies to promote spinal cord repair.

Authors:  Christopher M Walthers; Stephanie K Seidlits
Journal:  Biomark Insights       Date:  2015-04-09

Review 6.  Concepts for regulation of axon integrity by enwrapping glia.

Authors:  Bogdan Beirowski
Journal:  Front Cell Neurosci       Date:  2013-12-19       Impact factor: 5.505

7.  The therapeutic effects of bone marrow mesenchymal stem cells after optic nerve damage in the adult rat.

Authors:  HaiBo Tan; Xin Kang; ShiHeng Lu; Lin Liu
Journal:  Clin Interv Aging       Date:  2015-02-16       Impact factor: 4.458

Review 8.  Sustained delivery of neurotrophic factors to treat spinal cord injury.

Authors:  Aikeremujiang Muheremu; Li Shu; Jing Liang; Abudunaibi Aili; Kan Jiang
Journal:  Transl Neurosci       Date:  2021-11-30       Impact factor: 1.757

9.  Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity.

Authors:  Xing Li; Yuan Zhang; Yaping Yan; Bogoljub Ciric; Cun-Gen Ma; Bruno Gran; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2016-05-16       Impact factor: 11.454

Review 10.  The Dorsal Column Lesion Model of Spinal Cord Injury and Its Use in Deciphering the Neuron-Intrinsic Injury Response.

Authors:  Callan L Attwell; Mike van Zwieten; Joost Verhaagen; Matthew R J Mason
Journal:  Dev Neurobiol       Date:  2018-05-11       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.